Head to head
Rocket Lab vs SpaceX
Side-by-side on the measures that matter, with a plain-English read. Full detail: RKLB · SPCX
RKLB
Rocket Lab
45.42-10.92%
1-year price shape — +15% over the period
Quant Rating D · 45/100
vs
SPCX
SpaceX
127.79-7.69%
1-year price shape — not enough history yet
Quant Rating C · 0/100
1-year performance, rebased to 100
SpaceX edges it on the scoreable measures.
| RKLB | SPCX | |
|---|---|---|
| Snapshot | ||
| Sector | Aerospace & Defense | Aerospace & Defense |
| Last price | 45.42 | 127.79 |
| Change today | -10.92% | -7.69% |
| 1-year return | +15.0% | -- |
| Market cap | $28.71B | $1.74T |
| 52-week range | 39.30 – 151.00 | 104.83 – 225.64 |
| Valuation | ||
| P/E (TTM) | -122.76 | -505.10 |
| P/E percentile, own 5-yr range | 21st | 12th |
| P/B | 4.95 | 9.82 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | -0.37 | -0.38 |
| Net profit (TTM) | $-233.85M | $-5.13B |
| Revenue (TTM) | $881.90M | $32.04B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +72.7% | +161.4% |
| Gross margin | 36.2% | 56.7% |
| Operating margin | -27.6% | -2.0% |
| Net margin | -25.7% | -10.7% |
| Free cash flow (TTM) | $-325.62M | $-40.16B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 58.4% | 30.3% |
| Insider activity (12mo) | 13 buy / 35 sell | 5 buy / 5 sell |
| Short interest (% of float) | 7.4% | 1.0% |
| Analyst consensus | 88% buy / 12% hold (17) | 87% buy / 10% hold / 3% sell (30) |
| Analyst price target | $98 (+115%) | $258 (+102%) |
| StockVane view | ||
| StockVane Quant Rating | D (45) | C (0) |
| Company | ||
| Employees | 2,600 | 22,000 |
| Founded | 2006 | 2002 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.